shadow_tr

Rodney E. Shackleford, DO, PhD

Rodney E. Shackelford, D.O., Ph.D.



Assistant Professor

Education:

Western Washington University    BA    06/85
Western Washington University    BS    03/86  
Duke University Medical Center    Ph.D.    12/94  
Des Moines University of Osteopathic Medicine   
Doctor of Osteopathic Medicine    05/03   


Positions and Employment

1995 – 1996    Postdoctoral Fellow, Duke University Medical Center, Department of Pathology
1996 – 1999    Postdoctoral Fellow, National Institute of Environmental Health Services
04/03 – 06/03    Postdoctoral Fellow, Stoddard Cancer Research Institute, Des Moines, IA
2003 – 2007    Pathology Resident, Louisiana State University Health Sciences Center, Shreveport, LA
2007 – 2009    Molecular Pathology Fellow, Johns Hopkins Hospital, Baltimore MD
2009 – 2010    Oncologic Surgical Pathology Fellowship, Moffitt Cancer Center, Tampa, FL


Awards and Honors

Marquis Who’s Who in America
One of three winners of the Albert G. Smith Resident Research Forum Award
Marquis Who’s Who in Science and Engineering
Marquis Who’s Who in Medicine and Healthcare & Who’s Who in America
Stowell-Orbison Award Certificate of Merit for poster presentation at the United States and Canadian Academy of Pathology Meeting. Atlanta, GA.
Continental Who’s Who Registry of National Business Leaders
Young Investigator Award from the Association for Molecular Pathology
Granted a Special Certificate for excelling in the area of Psychiatry and Behavior Medicine while attending Des Moines University of Osteopathic Medicine
Chosen to display a poster at the Eighth Annual American Medical Student Associations Poster Session. A travel award was also received to cover travel costs.
A Research/Publication Scholarship of $1,000 from Des Moines University of Osteopathic Medicine
Strathmore’s Who’s Who in America
Poster at the Sixth Annual American Medical Student Associations Poster Session
Received a Junior Investigator Fellowship travel award for the Kern Aspen Lipid Conference
Accepted into the Summers of Discovery Program at the National Institute of Environmental Health Sciences
Received Merit Scholarship Award from Des Moines University of Osteopathic Medicine
Travel Award from the American Association for Cancer Research-Pharmacia & UpJohn Young Investigator Award for travel to the American Association for Cancer Research, 90th meeting
Free associate membership in American Association for Cancer Research
National Research Service Award


Completed Research Support

2006   
The A-T Children’s Project, $5,000
Increasing A-T Cell Viability by Pharmacologic Modulation of Intracellular Nicotinamide Adenine Dinucleotide Levels, The Johns Hopkins Hospital (Co-Investigator: Rodney E. Shackelford with Dr. Howard Lederman)

2005   
The A-T Children’s Project, $8,500
Deferrioxamine as a Pharmacologic Treatment to Increase A-T Cell Viability, Louisiana State University
(Co-Investigator: Rodney E. Shackelford with Dr. Anping Chen)

2003   
The A-T Children’s Project, $25,000
Desferrioxamine as Pharmacologic Treatment of Increase A-T Cell Viability, Human Gene Therapy Research Institute (Rodney. E Shackelford)

2002   
The A-T Children’s Project, $3,000
Desferrioxamine as Pharmacologic Treatment of Increase A-T Cell Viability, Human Gene Therapy Research Institute.  (Rodney E. Shackelford)

2001   
The American Federation for Aging Research, $5,000
Ataxia-telangiectasia, Gene Therapy and the Cellular Aging Process, Des Moines University of Osteopathic Medicine (Rodney E. Shackelford)

 

Research Publications

1.    Shackleford RE, Fu Y, Manuszak RP, Brooks TC, Sequeira AP, Wang S, Lowery-Nordberg M, and Chen A.: Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells. DNA Repair 2006;5:1327-36

2.    Shackelford RE, Manuszak RP, Johnson CD, Hellrung DJ, Link CJ, and Wang S: Iron chelators increase the resistance of ataxia-telangiectasia cells to oxidative stress. DNA Repair 2004;3:1263-72.

3.     Qi J, Shackelford RE, Ryan Manuszak R, Cheng D, Smith, Link CJ Jr, and Wang S: Functional expression of ATM gene carried by HSV amplicon vector In Vitro and In Vivo. Gene Ther 2004;1:25-33.

4.    Shackelford RE, Mansuszak RP, Johnson CD, Hellrung DJ, Steele TA, Link CJ, and Wang S: Desferrioxamine treatment increases the genomic stability of Ataxia-telangiectasia cells. DNA Repair 2003;2:971-81.

5.    Heinloth AN, Shackelford RE, Innes CL, Bennett L, Li L, Amin RP, Sieber SO,     Flores KG, Bushel PR, and Paules RS: ATM-dependent and -independent     gene expression changes in response to oxidative stress, γ- and UV-Irradiation. Radiation Research 2003;160:273-90.

6.    Heinloth AN, Shackelford RE, Innes CL, Bennett L, Li L, Amin RP, Sieber SO, Flores KG, Bushel PR, and Paules RS: Identification of distinct and common gene expression changes after oxidative stress, γ- and UV-radiation. Mol Carcinog 2003;276:21951-9.



Dept. of Pathology & Laboratory Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 504-988-5224 tulpath@tulane.edu